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Human erythrocytes have been regarded as perfect osmom-
eters, which swell or shrink as dictated by their osmotic environ-
ment. In contrast, in most other cells, swelling elicits a regula-
tory volume decrease (RVD) modulated by the activation of
purinic and pyrimidinic receptors (P receptors). For human
erythrocytes this modulation has not been tested, and we thus
investigated whether P receptor activation can induce RVD in
these cells. Further, because ectonucleotidases may scavenge
ATP or ADP or act as a source for extracellular adenosine and
therefore modulate P receptor activation and RVD, we also
determined their activity in intact erythrocytes. We found
relatively low ectoATPase but significant ectoADPase and
ectoAMPase activities. When erythrocytes were exposed to
hypotonicmedium alone, they swelled as expected for an osmo-
metric response and showednoRVD.Activation of P2 receptors
by exogenous ATP or ADP did not trigger RVD, whereas P1
agonists adenosine and adenosine-5-N-ethylcarboxamide
induced significant RVD. The effect of adenosine-5-N-ethylcar-
boxamide was dose-dependent (maximal RVD of 27%; apparent
K1⁄2 of 1.6 1.7M). The RVD induced by adenosine was blocked
80% with the non-selective P1 antagonist 8-(p-sulfophenyl theo-
phylline)or theP1-A2B inhibitorMRS1754,butnotby inhibitorsof
P1 subtypes A1, A2A, and A3. In addition, forskolin (an inducer of
intracellular cAMP formation) could mimic the effect of adeno-
sine, supporting the idea of P1-A2B receptor activation. In conclu-
sion, we report a novel P1-A2B receptor-mediated RVD activation
in mature human erythrocytes and thus indicate that these long
held perfect osmometers are not so perfect after all.
Animal cells are much more permeable to water than to
osmolytes. In consequence, a reduction of extracellular osmo-
larity or an increase in the intracellular osmolarity leads to a net
influx of water and fast cell swelling. Because cells can only
expand to a certain limit before bursting, it is essential to coun-
teract this osmotic swelling. This is usually accomplished in a
process termed regulatory volume decrease (RVD),4 where
intracellular osmolarity is reduced by the release of organic and
inorganic osmolytes from the cell, together with osmotically
obligedwater and the concomitant reduction of cell volume (1).
Although RVD is observable in almost all animal cells,
the mature anucleated mammalian erythrocyte appears to
lack mechanisms of volume regulation. This is why as early
as 1950 Eric Ponder postulated that, within certain limits nor-
mal human red blood cells exist in osmotic equilibrium with
their solvent environments and behave as near-ideal volume
osmometers (2). Early studies on red blood cells (RBCs) from
normal adults, children, and newborn infants, varying consid-
erably in size, shape, and hemoglobin content, showed a close
agreement between the cell volume values for an expected
osmometric response and the average cell volumes determined
at each tonicity (3, 4). This lack of RVD is quite exceptional
given that erythrocytes from almost all other vertebrate species
studied so far display a measurable volume regulation (5–9).
The swelling activated response usually involves an increase
of KCl co-transport, as in duck, sheep, rabbit, and mouse red
cells (10, 11), but may also involve formation of a channel that
mediates the efflux of osmolytes such as taurine, as in red cells
from skate and trout (7, 12). In human RBCs, however, volume-
sensitive efflux of KCl and RVD appear to be restricted to
reticulocytes, which, under normal conditions, comprise only
0.5–1.5% of the whole erythrocyte population. Also, mouse
anion exchanger band3/AE1 protein, the homolog of which is
involved in RVD of trout erythrocytes (13), when expressed in
Xenopus oocytes displays neither channel activity nor transport
of organic osmolytes. This was consistent with the current idea
that transport pathways for RVD remain inactivated in mature
mammalian RBCs (14). In contrast, in isotonic conditions
mammalian erythrocytes are capable of losing water via KCl
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co-transport activity as well as Ca2-activated K channels
known as Gardos Channels (KCNN4 (15)).
Although these findings established an empirical and theo-
retical basis to explain the lack of volume regulation of mature
mammalian erythrocytes, several lines of evidence demon-
strated that, not only the absence or presence of effector mech-
anisms, but also signaling events have to be taken into account.
Specifically, it was shown byWang et al. (16) that swollen hep-
atoma cells required endogenous extracellular ATP to down-
regulate cell volume (16).
Further examples of ATP-induced volume regulation were
observed in nucleated erythrocytes from the salamander Nec-
turus (9) and in hepatocytes, endothelial cells, astrocytes, and
epithelial cells from human and several other mammalian spe-
cies (1). Similarly, RVD was activated by UTP in salivary gland
duct cells (17) and by ATP, UTP, UDP, or ATPS in trout and
goldfish hepatocytes (18, 19).
Moreover, extracellular adenosine, derived from hydrolysis
of extracellular ATP, was shown to inhibit RVD via P1 activa-
tion in fish hepatocytes (18, 19). Thus, it seems clear that under-
standing volume regulation requires an understanding of
events involved in nucleoside signaling on the cell surface.
The main players in this regard appear to be extracellular
nucleotides, cell surface P receptors (including purinic and
pyrimidinic receptors; see Ref. 20), and ectonucleotidases. In
mammals, 19 P receptors have been cloned, which belong to
two main categories, i.e. P1 receptors with high affinity for
adenosine and P2 receptors preferentially binding nucleoside
di- and triphosphates (21). The P2 receptors have been further
subdivided into P2X (ligand-gated ion channels) and P2Y
(receptors coupled to a G-protein). Although P receptors are
ubiquitous in almost every cell system, there is little informa-
tion concerning their presence in vertebrate erythrocytes. In
human mature RBCs the ADP receptor sub-type P2Y13 is the
most abundantly expressed on the mRNA level, whereas other
P2 receptors (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2X1,
P2X4, and P2X7) display very low levels (22, 23). Up to date, P1
receptors have not been studied in this cell system.
In human blood, several processes act to metabolize extra-
cellular ATP; conversion of ATP to ADP and AMP is mainly
promoted by the activities of ectonucleoside triphosphate dihy-
drolases (E-NTPDases) from leukocytes and endothelial cells,
with little or no contribution of plasma, platelets, or erythro-
cytes. The dephosphorylation of AMP to adenosine is primarily
mediated by a soluble 5-nucleotidase of the plasma (24).
Regardless of the bulk concentrations of nucleosides present in
the plasma, P receptor signaling of erythrocytes will also
depend on the capacity of ectonucleotidases present at the sur-
face of these cells. Regarding this, isolated human erythrocytes
display significant hydrolysis rates of extracellular AMP and
ADP, and very low ectoATPase activity (25). However, no stud-
ies weremade on ectonucleotidases of specific erythrocyte sub-
populations that would allow discriminating between mature
anucleated cells and reticulocytes.
Based on the main processes that govern RVD as well as the
homeostasis of extracellular nucleotides, amodel for autocrine/
paracrine modulation of RVD by ATP was proposed (26). In
this model, cell swelling causes a non-lytic, regulated release of
ATP, which would then stimulate specific P2 receptors and
thereby activate the efflux of osmolytes and water, in this way
promoting the recovery of cell volume (16). But although this is
relatively well established, little is known regarding the poten-
tial action of P1 on volume regulation. This, however, would
seem of importance, insofar as ATP can readily interconvert to
its hydrolysis products in the extracellular space, and adeno-
sine, derived fromATP, ADP, or AMP,may then accumulate in
significant concentrations at the cell surface. For example, in
pig red cells, adenosine and adenosine analogs were able to
inhibit a volume-sensitive chloride-dependent K flux,
although induction of the response required relatively long
incubation times and millimolar concentrations that were sev-
eral orders higher than the EC50 values of all known P1 recep-
tors (27). In airway epithelial cells ATP released upon swelling
was rapidly hydrolyzed to adenosine, followed by adenosine
activation of volume-sensitive anion channels. Unfortunately,
the corresponding kinetics of cell volume was not studied (28).
In the present study we sought to investigate whether extra-
cellular adenine nucleotides and adenosine are able to trigger
RVDofmature human erythrocytes. Our approach included an
assessment of time-dependent volume changes of cells in the
presence of exogenous nucleosides, as well as the use of selec-
tive antagonists to identify the specific P receptormediating the
regulatory response. Furthermore, because extracellular nu-
cleosides can be metabolized in the extracellular space, gener-
ating different P receptor agonists, we determined ectonucle-
otidase activities using intact cells.
EXPERIMENTAL PROCEDURES
Reagents
Poly-D-lysine, ATP, ADP, 2-methylthioadenosine 5-di-
phosphate (2MeS-ADP), AMP, adenosine, adenosine-5-N-
ethylcarboxamide (NECA), 8-sulfophenyl theophylline (8-
SPT), 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), nigericin,
adenosine deaminase (type V), and Percoll were purchased
from Sigma. 4-(2-{[5-Amino-2-(2-furyl)[1,2,4]triazolo[1,5-a][1,
3,5]triazin-7-yl]amino}ethyl)phenol (ZM241385), 2-phenoxy-
6-(cyclohexylamino)purine hemioxalate (MRS3777), andN-(4-
cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-
1H-purin-8-yl)phenoxy]acetamide (MRS1754) were fromToc-
ris Bioscience (Bristol, UK). The 2,7-bis-(2-carboxyethyl)-5-
(and-6)-carboxifluorescein, acetoxymethyl ester (BCECF-
AM) was obtained from Molecular Probes (Eugene, OR).
[-32P]ATP (5.4 Ci mg1, 10 mCi ml1) was from
PerkinElmer Life Sciences. All other reagents were of analytical
grade.
Cells
Ten milliliters of heparinized blood was obtained from
healthy volunteers who had not received a transfusion within
3 months.
After blood centrifugation (900  g at 25 °C for 3 min),
plasma, platelets, and leukocytes were removed by pipetting,
and erythrocytes were washed three times in RBC medium (in
mM: 155 NaCl, 2.7 KCl, 1.5 KH2PO4, 2.5 Na2HPO4, 1 CaCl, 1
MgSO4, 5 glucose, pH  7.4, 20 °C, osmolarity  300 mosM).
Final hematocrit was 45%. All experiments shown in this
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studywere performedwith a subpopulation of RBCs containing
only anucleated mature erythrocytes isolated by means of a
discontinuous Percoll density gradient (29). Briefly, five solu-
tions of modified RBC medium (in mM: 155 NaCl, 2.7 KCl, 1.5
KH2PO4, 2.5 Na2HPO4, 5 glucose, and 5% bovine serum albu-
min, pH  7.4, 20 °C, osmolarity  300 mosM) were prepared
with a final Percoll concentration of 60%, 66%, 70%, 74, and 80%
(density 1.087–1.098 g ml1). Discontinuous Percoll gradients
were made by careful manual pipetting of 1 ml of 80% solution,
3 ml of 74%, 3 ml of 70%, 3 ml of 66%, and 1.5 of ml 60%. Finally
1.5 ml of erythrocyte suspension containing5.5–6.5 109 cells
was seeded on top of the gradient. Centrifugation was carried
out in a Sorvall RC-2B in a fixed angle rotor (SS-34) at 4000 g
for 15 min at 20 °C. Cell fractions were collected by aspiration,
and the middle fractions (interphase 66–70% and 74–80%)
were washed three times in RBC medium (900 g at 25 °C for
3min) to eliminate the remaining Percoll. In preliminary exper-
iments no cells of these middle fractions stained with methyl-
ene blue, indicating that no reticulocytes were present (30).
In experiments of Fig. 1, where an assay medium lacking
phosphate was required, separation of the erythrocytes was fol-
lowed by three washes of the cell suspension in RBC-Hepes
medium (in mM: 130 NaCl, 4.7 KCl, 1.5 CaCl, 1.1 MgSO4, 5
NaHCO3, 10 glucose, 20 HEPES, pH 7.4, 20 °C, osmolarity
300 mosM). To remove intracellular phosphate, cells were then
incubated in RBC-Hepes for 1 h at 25 °C and thenwashed twice
with RBC-Hepes. All procedures conformed to the Declaration
of Helsinki, and written informed consent was given by the
subjects.
Ectonucleotidase Activity
Red blood cells do not take up ATP, ADP, or AMP. There-
fore, following addition of adenine nucleotides to a cells sus-
pension, the rate of phosphate accumulation in themedium is a
measure of ectoATPase (from ATP), ectoADPase (from ADP),
and ectoAMPase (from AMP) activities.
EctoATPase activity was determined by following the release
of [-32P]Pi from [-32P]ATP as described before (31, 32) with
modifications. Briefly, the reaction was started by adding 300
M [-32P]ATP to cell suspensions (20% average hematocrit) at
20 °C under continuous stirring. At different times, a 200-l
aliquot of the suspension was withdrawn and centrifuged at
20,000  g during 30 s, and 100 l of the supernatant were
poured into 750 l of a stop solution containing 4.05 mM
Mo7O24(NH4)6 and 0.83 mM HClO4. The ammonium molyb-
date solution formed a complex with the released phosphate,
which was then extracted by adding 0.6 ml of isobutyl alcohol
under vigorous stirring.After the phaseswere separated by cen-
trifugation for 5 min at 1,000  g, aliquots of 200 l of the
organic phase containing [-32]Pi were transferred to vials con-
taining 2.5 ml of 0.5 M NaOH. Radioactivity was measured by
using the Cerenkov effect.
EctoADPase and ectoAMPase activities were determined
with a malachite green method (33). Briefly, cell suspensions
(15% average hematocrit) were incubated with 300 M of ADP
or AMP at 20 °C under continuous agitation. At the indicated
times, 200-l aliquots were centrifuged at 20,000  g for 30 s,
and 150l of the supernatant wasmixedwith 650l of ice-cold
bidistilled water. 200 l of the malachite green reagent (con-
taining 3.05 mM malachite green, 4.72 N H2SO4, 12 mM
Mo7O24(NH4)6, and 0.16% Tween 20) were added, followed by
100 l of 1.37 M Na citrate. Solutions were incubated at 20 °C
for 30min, and absorbancewas determined at 630 nm. Absorb-
ance values were converted to phosphate concentration by
means of a calibration curve (2–20 nmol of Pi ml1).
In both methods, care was taken to obtain initial rate values.
Values of phosphate concentration in assay medium lacking
cells were subtracted from the phosphate accumulation in the
presence of cells at each time point. Although phosphate con-
tent in the absence of cells was higher than zero, it did not
increase with time, i.e. phosphate production was negligible.
Cell Volume
Relative cell volumes before and after osmotic cell swelling
were estimated at room temperature by two different methods
as follows.
Method 1: BCECF Fluorescence Quenching—Under certain
conditions fluorescence intensity decreases with the increase in
fluorophore concentration. This quenching property can be
used for measuring water volume changes in cells (34). In the
following, a brief description of the method used to estimate
cell volume by fluorescence quenching of BCECF-loaded eryth-
rocytes is given.
Human erythrocytes (3.5  106) were attached to 0.001%
poly-D-lysine-coated coverslips. At this very low concentration
of poly-D-lysine cells remain discoidal in shape (35).
Erythrocytes were incubatedwith RBCmedium containing 5
MBCECF-AMduring 60min at 20 °C. Subsequently, the solu-
tion was washed with RBC medium for 30 min to eliminate
extracellular BCECF, and the coverslip was mounted on a
recording chamber in aNikonTE-200 epifluorescence inverted
microscope. During experimental manipulations, all media
were removed from or introduced in the chamber manually.
Changes in cell water volume were inferred from readings of
the fluorescence intensity recorded by exciting BCECF at 445
nm, where the fluorochrome is pH-insensitive (the isosbestic
point; see below).
In preliminary experiments erythrocytes were exposed to
anisotonic solutions so as to alter cell volume. It was seen
that, as cell volume increases, fluorescence intensity in-
creased, and similarly, as cell volume decreases, fluorescence
intensity decreased with increasing fluorophore concentration.
Thus, the directly proportional relationship between fluores-
cence intensity and cell volume was interpreted as a result
of fluorescence quenching, and changes in fluorescence
intensity recorded from a small region of dye-loaded cells
(pinhole) reflect alterations of cell water volume. As an exam-
ple, Fig. 2B shows results of relative cell volume (Vr) versus
relative osmolarity of erythrocytes exposed to hypotonic media
from the experiments performed in this report. Fluorescence
images were acquired by use of a charge-coupled device camera
(Hamamatsu C4742–95) and the Metafluor acquisition pro-
gram (Universal Imaging).
Calibration was performed by sequentially exposing cells to
assay media of osmolarities of 300, 285, 270, and 255 mosM.
The hypotonic media for cell volume calibrations and HYPO
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medium had a similar composition as isotonic RBC medium,
except that the NaCl concentration was lower.
Values of relative cell volume (Vr) were obtained from the
relative fluorescence (Ft/F0), with F0 representing the signal
obtained from a pinhole region of the cell equilibrated with
isotonic medium, and Ft denoting the fluorescence of the
same region of the cell at time t. Thus Vr represents a frac-
tional volume, where the initial isotonic cell volume value is
1, and volume changes are expressed as relative to the initial
value. In some cases we found small but constant changes in
fluorescence intensity in individual cells that can be due to a
leak and/or photobleaching of the fluorophore. When this
happened, the drift in fluorescent intensity was corrected
using data from isotonic exposure. In other cases, individual
cells had a non-constant change in fluorescence intensity or
a fast loss of fluorescence intensity, a process compatible
with a fast increase in plasma membrane permeability,
and cell death. These cells were not used for analysis.
Examples of these considerations can be found in
supplemental Fig. S1.
Because BCECF is sensitive to pH, knowledge of the precise
isosbestic point is critical to avoid pH interference on the vol-
ume signal. Therefore, pH-dependent changes of BCECF spec-
tra were analyzed as follows.
Suspensions of human erythrocytes (1% hematocrit) were
incubated with RBC containing 5 M BCECF during 60 min,
and then washed three times by centrifugation at 20,000 g
for 30 s. Afterward the cells were incubated in 300 l of
modified RBC containing 1 M of the K/H exchanger
nigericin and a KCl concentration similar to the cytoplasmic
K concentration. Under these conditions, this procedure
assures rapid equilibration of K and H concentrations in
the intra- and extracellular compartments, so that the values
of intra- and extracellular pH are equal. For obtaining the
spectra, erythrocyte suspensions (0.032% hematocrit) were
incubated in an AMINCO-Bowman series 2 spectrofluoro-
meter (Thermo Fisher, Waltham, MA) at 20 °C under con-
stant agitation. For each run the pH of the extracellular solu-
tion was modified by HCl addition, and time measurements
of fluorescent intensity were recorded at 530  4 nm (with
490  4 nm excitation wavelength) until a stationary value
was achieved. Then, excitation spectra were recorded at
530 4 nm with excitation wavelengths ranging from 300
2 nm to 500  2 nm.
Method 2:MicrohematocritMethod—Cell suspensions (1.9–
2.8 109 cells ml1) were loaded into 80-l capillary tubes (75
mm in length) and centrifuged at 10,000 g for 2 min. Relative
volume was calculated from the relative length occupied by
cells, as compared with total length of the suspension.
RVD Computation
The RVD associated with the cellular volumetric response
was calculated by Equation 1,
RVD
Vrmax	 Vrt	
Vrmax	 1
 100 (Eq. 1)
where Vr(max) is the maximal value of Vr attained during hypo-
tonic swelling, and Vr(t) represents the value of Vr observed at
different times after reaching Vr(max). RVD thus denotes the
magnitude of volume regulation, with 100% RVD indicating
complete volume regulation. In all cases we calculated the
extent of RVD observed 40 min after Vr(max).
Mathematical Analysis
In experiments in Fig. 4, intact erythrocytes were used to
assess the effect of exogenousNECA (0.5–4M) onRVD.Next,
Equation 2 was fitted to experimental data,
RVD RVDHYPO
RVDmax
NECA
K1⁄2 
NECA
(Eq. 2)
where RVDmax denotes the apparent maximal RVD and K1⁄2 is
the substrate concentration at which a half-maximal RVD is
obtained under the specific conditions of the experiment.
FIGURE1.Ectonucleotidaseactivityof intact erythrocytes.A, timecourseof Pi accumulation (nanomolesof Pi (10
10 cells)1) using300Mof eitherATP (open
circles), ADP (closed circles), or AMP (gray triangles). The continuous lines are linear regressions to experimental data,with the corresponding slopes representing
ectoATPase (from ATP), ectoADPase (from ADP), and ectoAMPase (from AMP) activities. For each condition, accumulation of Pi in the absence of cells was
subtracted (see “Experimental Procedures”).B, ectoATPase, ectoADPase, andectoAMPase activities calculated fromexperimental dataofA. Results aremean
S.E., n 10.
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RVDHYPO represents the RVD obtained in the absence of
extrinsic modulators.
Statistics
The absence or presence of RVDwas evaluated by determining
whether the slopeofVr versus timewas significantlydifferent from
0 (p  0.05), using a Pearson correlation test. The effect of the
different treatments on RVD was evaluated by means of one-way
analysis of variance followed by a Tukey-Kramer test of multiple
comparisons. A p value of0.05 was considered significant. In all
of the experiments, number of cells (n) and number of indepen-
dent preparations (N) are indicated.
RESULTS
Ectonucleotidase Activity—In light of the suggested role of
ATP and its hydrolysis products in the volume regulatory
response of RBCs, the first series of experiments investigated
the capacity of these cells to hydrolyze adenine nucleotides by
membrane-bound enzymes called ectonucleotidases. Because
nucleotides, unlike adenosine, are not taken up by intact cells,
the rate of extracellular hydrolysis is a measure of ectoATPase
(from ATP), ectoADPase (from ADP), and ectoAMPase (from
AMP) activities.
In the presence of 300 M of any of the nucleotides, Pi accu-
mulation increased linearly (Fig. 1A). EctoATPase activity was
0.26 0.04 nmol of Pi (1010 cells min)1, whereas ectoADPase
and ectoAMPase were 1.49 0.29 nmol of Pi (1010 cells min)1
and 1.57 0.42 nmol of Pi (1010 cells min)1, respectively. Fig.
1B shows that ectoADPase and ectoAMPase activities were7
times higher than ectoATPase activity. Similar experiments
in the absence of cells showed no significant Pi accumulation
(p 0.37–0.55).
FIGURE2.A, excitation spectraof BCECF-loadederythrocytes. Cells (0.032%hematocrit)were incubated in isotonichighpotassiummediaofdifferentpHvalues
(6.02–7.80) in thepresenceof 1Mnigericin. Emissionwavelengthwas set to5304nm, andexcitation spectrawere recordedby illuminating the samplewith
light of 300–500 2 nm. The inset shows a zoom of results for excitation range from 420 to 460 nm, with the vertical line denoting the isosbestic excitation
wavelength. B, osmotic response of RBCs. Values of relative volume (Vr) are plotted as a function of relative osmolarity in the intracellular (osmiso) and
extracellular (osme) compartments. The closed circles show Vr values for cells exposed to hypotonic calibration media. The continuous line represents a linear
regression to Vr values.
FIGURE 3. Effect of P2 agonist on the relative volume (Vr) of erythrocytes exposed to hypotonic medium. A, kinetics of Vr estimated by fluorescence
quenchingof BCECF. Cellswere exposed to isotonicmedium (C) andhypotonicmedium (HYPO) in the absence (closed circles) andpresenceof 300MATP (gray
circles), 50 M ADP (gray triangles), 150 M ADP (open triangles), or 150 M 2MeS-ADP (open circles). Results are means S.E., n 60, n 4. B, relative volume
(Vr) versus time of erythrocytes exposed to isotonic medium (C) and HYPO in the absence (closed circles) and presence of 150M 2MeS-ADP (open circles), 150
M 2MeS-ADP plus 1 unit ml1 adenosine deaminase (ADA; gray circles) or 150M 2MeS-ADP plus 100M 8-SPT (open triangles). Results aremeans S.E., n
60, n 4. The same results for HYPO (closed circles) and HYPO plus 150 M 2MeS-ADP (open circles) were used in A and B.
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Volumetric Measurements—Relative cell volume (Vr) was
measured by BCECF fluorescence quenching and in selected
experiments with the hematocrit method.
Because BCECF is sensitive to intracellular pH, volume
measurements had to be performed by exciting cells at the exci-
tation isosbestic wavelength. Accordingly, prior to the Vr mea-
surements, excitation spectra of BCECF-loaded erythrocytes
were analyzed using media with different pH values ranging
from 6.02 to 7.8 (see “Experimental Procedures”). It can be seen
that changes in fluorescence with pH become negligible at 445
nm (Fig. 2A), therefore all subsequent Vr measurements were
made by evaluating fluorescence quenching at an excitation
wavelength of 445 5 nm.
Volumetric Response inHypotonicMedium—During calibra-
tion of the signal, Vr was measured in isotonic medium, fol-
lowed by brief exposure to a series of media of increasing hypo-
tonicity and later to isotonic medium again. Then, cells were
exposed to a 210mosM hypotonicmedium (HYPO), andVr was
monitored in the absence or presence of different compounds.
As shown in Fig. 2B, there was a linear relationship between the
osmotic ratio in the intracellular and extracellular compart-
ments and the calculated Vr for the calibration media.
In a first series of experiments, we evaluated the effect of
HYPO when applied alone or in the presence of either ATP,
ADP, or 2MeS-ADP (a potent agonist of P2Y12 and P2Y13
receptors, known to be present in these cells). In HYPO, cells
swelled to a maximum Vr value of 1.30 0.01, which remained
constant thereafter. In the presence ofHYPOwith 300MATP,
a slight RVD could be calculated amounting to 8.8 3.1%, but
this was not statistically significant (p 0.31). A similar result
was obtained with 50 M ADP (9.6  3.8%; p  0.10). On the
other hand, significant RVD values of 21.8  4.6% and 45.5 
3.9% were obtained with 150 M ADP or 150 M 2MeS-ADP,
respectively (Fig. 3A). However, these concentrations were
200–6000 times higher than the EC50 values for all known P2Y
receptors. This fact together with the finding that both 100 M
FIGURE 4. Effect of P1 receptor modulation on the relative volume (Vr) of erythrocytes under hypotonicity. A, kinetics of Vr estimated by fluorescence
quenching of BCECF at 20 °C. Cells were exposed to isotonic medium (C) and hypotonic medium (HYPO) in the absence (closed circles) and presence (gray
triangles) of 2 M adenosine (ADO). The open circles show control experiments where cells were exposed to an isotonic medium containing 2 M adenosine.
Results are means  S.E., n  60, n  4. B, values of RVD at 40 min estimated from experiments shown in A. *, p  0.05 versus HYPO. C, Vr versus time for
erythrocytes exposed to isotonicmedium (C) and HYPO at 37 °C in the absence (closed circles) and presence (gray triangles) of 2M adenosine (ADO).D, values
of RVD at 120min estimated from experiments shown in C; the RVD at 120min obtained bymicrohematocrit method of cells exposed to HYPO at 37 °C plus 2
M adenosine (HC) is also plotted. *, p 0.05 versus HYPO.
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8-SPT (a P1 blocker) as well as 1 unit ml1 of adenosine deami-
nase (that converts the P1 agonist adenosine to the non-P1
agonist inosine in the extracellular space) blocked 80–84% of
the effect of 150 M 2MeS-ADP (Fig. 3B) make the observed
responses unlikely to be mediated by P2 receptors and point
toward a putative novel P1 modulation of RVD in erythrocytes.
Effect of P1Activation on RVD—In isotonicmedium contain-
ing 2 M adenosine no changes in cell volume were detected,
whereas in HYPO plus 2 M adenosine, cells initially swelled to
1.39 0.01 and then displayed a significant RVD (15.9 2.2%;
Fig. 4, A and B). Similar to experiments at room temperature,
exposure of erythrocytes to HYPO at 37 °C (a more physiolog-
ical temperature) caused an increase of Vr to 1.34  0.01, and
the cells subsequently remained swollen without significant
loss of cell viability for 175 min (Fig. 4C). When the cells were
exposed to HYPO at 37 °C plus 2 M adenosine, a significant
RVD was detected (23.8 4.4% at 120 min). Unexpectedly, the
RVD found at 37 °C seemed to occur at a somewhat slower rate
than the one found at 20 °C, because at 37 °C volume recovery
after 55 min reached 16%, whereas a similar value was reached
after only 40min at room temperature. Although the reason for
this remains unknown at present, these results nonetheless
clearly show that the qualitative response remained unaltered
at 37 °C.
The use of a microhematocrit method to measure cell vol-
ume under HYPO at fixed times provided similar results as
those of the fluorescence-quenching method. In the absence of
extrinsic modulators the hypotonic challenge led to no RVD,
whereas the addition of adenosine (i.e. HYPO plus 2 M aden-
osine at 37 °C) led to RVD120 of 24% (fluorescence quenching)
and 29% (microhematocrit) (Fig. 4D).
The involvement of P1 in RVDwas further evaluated by per-
forming a dose-response curve forNECA (a potent analog of P1
receptors). Each data point in this dose-response curve is a
value of the percentage of RVD calculated after exposing the
cells to isotonic medium, followed by HYPO containing 0, 0.5,
2, and 4 M NECA and assessment of Vr kinetics in different
experiments (Fig. 5A). There was a concentration-dependent
effect of NECA on RVD (Fig. 5B). A hyperbolic fit to experi-
mental data yielded amaximal RVD (RVDmax; asymptotic value
of RVD at non-limiting agonist concentration) of 26.8  9.5%
and an apparent K1⁄2  1.61 1.68 M.
Then we analyzed the effect of P1 antagonists on the ade-
nosine-induced RVD. As shown in Fig. 6 and supplemental Fig.
S2, the RVD observed with 2 M adenosine could be inhibited
81.3  15.5% with 100 M 8-SPT, a known blocker for all P1
subtypes. In contrast, specific antagonists for A1 (DPCPX, 20
nM), A2A (ZM241385, 10 nM), and A3 (MRS3777, 250 nM) only
produced a non-significant 14–24% inhibition of RVD. Next,
we used the P1 antagonist DPCPX at 100 nM, a concentration at
which it can block bothA1 andA2B receptors (36). Accordingly,
in cells exposed to 100 nM of DPCPX and 2 M ADO, RVDwas
reduced by 65.9 8.4%. Finally, we found that 10 nM of the A2B
antagonist MRS1754 was able to inhibit 77.7  15.3% of the
RVD observed with adenosine. Regarding RVD in cells exposed
to HYPO plus 100 M 8-SPT, after the initial swelling we
observed a transient decrease ofVr followed by a slight increase
(see supplemental Fig. S2). At present we have no explanation
for this phenomenon, but because cell volume remained subse-
quently unaltered, this did not change the overall lack of vol-
ume regulation.
The experiments using selective antagonist of P1 receptors
indicate that A2B receptors are involved in RVD of human
erythrocytes. Because these receptors signal toward an increase
in cAMP concentration, in another set of experiments at 37 °C,
we used 100 M forskolin to increase intracellular cAMP con-
centration. As shown in Fig. 7, forskolin was indeed able to
induce RVD in these cells, supporting the idea of A2B receptor
activation during RVD.
DISCUSSION
Within 1 day the human reticulocyte leaves the bonemarrow
and becomes a mature erythrocyte. During maturation reticu-
locytes undergo substantial morphological and biochemical
changeswhere the loss of the nucleus and other organelles inac-
tivates protein synthesis and oxidative phosphorylation.
FIGURE 5. Dependence of RVD on the P1 agonist NECA. A, Vr versus time for human erythrocytes exposed to isotonic medium (C), followed by hypotonic
mediumcontaining0 (closed circles), 0.5 (open circles), 2 (gray triangles), or 5MNECA (gray circles). Results are expressedasmeans S.E.,n60,n4.B, values
of RVD (%) calculated for each NECA concentration shown in Fig. 4A. The continuous trace represents the fit by nonlinear regression of a single hyperbola to
data. Results are expressed as means S.E., n 60, n 4.
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In the course of this process, reticulocytes lose membrane
material, including transporters, and this is accompanied by a
reduction of water content and volume, and a progressive inac-
tivation of volume regulatory mechanisms (37). Thus, in
mature RBCs exposed to anisotonicity, changes in cell volume
are assumed to be solely governed by transmembrane water
fluxes that dissipate the difference in water chemical potential
of the intra- and extracellular compartments. This is why, on
average, cell volume follows a fairly good straight line when
plotted against the inverse of the extracellular osmolarity (2),
i.e.mature RBCs behave as an osmometer.
The main finding of the present study is that a small but
significant volume regulation can nonetheless be activated
when extracellular factors are considered, challenging the con-
ventional view regarding the purely osmometric behavior of
these cells. That is, following hypotonic swelling of mature
human RBCs, extracellular nucleosides may interact with spe-
cific P receptors to trigger a significant compensatory shrinkage
known as volume regulatory decrease.
As the stimulation of these receptors requires the presence of
the suitable ligands as well as control of their effective concen-
tration, we first investigated the presence and activity of corre-
spondingmembrane nucleotidases utilized for this function. In
fact, our experiments examining the hydrolysis of exogenous
nucleotides, a measure of ectonucleotidase activity of the cells,
showed that mature RBCs are indeed capable of hydrolyzing
ATP, ADP, and AMP, with ectoATPase activity being 7-fold
lower than ADPase and AMPase activities. This agrees well
with a previous study showing that, among RBCs examined in
40 vertebrate species, ectoATPase activity of human RBCs
ranks as the lowest (38). Furthermore, as other studies have
shown that ATP is released in human RBCs subjected to hypo-
tonicmedium (39), these enzymatic activities provide the phys-
iological basis for the control over the action of these nucleo-
tides on P receptors and in consequence one important level of
control over volume regulation.
In mature human RBCs, the effect of extracellular nucleo-
tides remained largely unexplored, mostly because of the abun-
FIGURE 6. Effects of antagonists of P1 receptors on RVD. A, mature human erythrocytes exposed to hypotonic media in the absence (HYPO) or presence of
2M adenosine alone (ADO) or 2M adenosine plus: 100M 8-SPT (ADO 8-SPT); 20 nM DPCPX (ADO DPCPX 20); 100 nM DPCPX (ADO DPCPX 100); 10 nM
ZM241385 (ADO  ZM241385); 10 nM MRS1754 (ADO  MRS1754); and 250 nM MRS3777 (ADO  MRS3777). Results are expressed as means  S.E. of the
percentage of inhibition of the effect of HYPO plus 2 M adenosine, n 60, n 4. *, p 0.05 versus ADO. B and C, results of Vr versus time of mature human
erythrocytes exposed to isotonic medium (C) followed by hypotonic media (HYPO) used to calculate results of A, only some of the results are shown to ease
visualization (all plots are shown in supplemental Fig. S2). The cells were exposed to HYPO in the absence (closed circles in B) or presence of 2 M adenosine
alone (ADO; open squares in C) or 100 nMDPCPX (ADODPCPX 100; gray squares in C); 10 nM ZM241385 (ADO ZM241385; open triangles in B); 10 nMMRS1754
(ADOMRS1754; closed triangles in C); and 250 nMMRS3777 (ADOMRS3777; gray circles in B). Results are expressed as means S.E., n 60, n 4.
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dant literature describing the osmometric behavior of this cell
model, a fact that agreed well with KCl co-transport (the main
potential effector system of RVD) being inactivated in swollen
cells (40). Only a single study, primarily devoted to volume reg-
ulation by extracellular ATP of Necturus erythrocytes, briefly
reported that a similar treatment exerted on human erythro-
cytes produced no RVD (41), but this was not followed up.
In the present study, we first exposedmature humanRBCs to
hypotonic medium in the absence or presence of exogenous
adenine nucleotides. We observed that neither ATP (up to 300
M) nor ADP (up to 50 M) were able to induce RVD. It is
important to mention that the concentrations of ATP and
ADP used in this report are well beyond those needed to
activate P2 receptors, particularly P2Y13 receptors, which,
according to Wang et al., are highly expressed in human
erythrocytes (23).
Accordingly, we turned our interest toward P1 receptors. In
mammals four types of P1 receptors, A1, A2A, A2B, and A3, have
been cloned, displaying convergent biochemical and pharma-
cological profiles (36). Our first results indicated that relatively
low micromolar concentrations of adenosine and NECA were
required to indeed induce a significant RVDof the erythrocytes.
This is, to our knowledge, the first report of volume regulatory
decrease of anucleated mammalian erythrocytes exposed to
hyposmotic medium. Because previous information regarding
expression of P1 receptor sub-types in mature RBCs was lack-
ing, we decided to address this issue by evaluating the impact of
various P1 blockers on ADO-induced RVD of RBCs. We
observed that 8-SPT could inhibit 81% of the RVD, whereas
specific agonists of A1, A2A, and A3 receptors had no effect. In
contrast, DPCPX, an agonist for A1 and A2B receptors, and
MRS1754, an agonist of A2B receptor, reduced 80 and 78% of
the RVD observed with adenosine alone. Together, these find-
ings suggest that, inmature humanRBCs, RVDcan be triggered
by A2B receptor activation. In support for this conclusion we
found that an activation of RVD may also be seen in the pres-
ence of forskolin, which increases intracellular cAMP concen-
trations (as does the activation of A2B receptor).
Altogether, our experiments thus suggested that in human
RBCs both the receptors that trigger RVD as well as nucleoti-
dases that may process these ligands are present. The fact that
ATPase activity was rather minor, however, indicated that, at
least in our in vitro model, the non-lytic release of ATP could
not lead to accumulation of adenosine, and therefore, as
directly observed in the volumetric experiments, an indirect
action of ATP on RVD is discarded.
In vivo the situation is far more complex, and to understand
the physiological relevance of the observed RVD response, the
following points should be considered: 1) Under normal condi-
tions low osmolarity does not appear to occur in the circulatory
compartment. Also, the pH in the spleen and other organs is
not sufficiently acidic to promote swelling of RBCs (42). None-
theless, in certain diseases, altered cation permeability may
result in volume perturbations, an example being overhydrated
hereditary stomatocytosis, where RBCsmay swell as solute and
osmotically obliged water are gained (43). Thus, transient
swelling may occur, at least under pathological conditions, and
require compensatory net osmolyte fluxes leading to cell
shrinkage. Furthermore, isosmotic swelling can take place in
erythrocytes leaving the renal papilla as urea is taken up (44). In
this respect, Joiner et al. have in fact previously reported the
occurrence of RVD of mature RBCs when pretreated with nys-
tatin (to increase cation content) and subsequently exposed to
strong stimulation with urea (45). However, in our hands aden-
osine could not induce RVDupon induction of isosmotic swell-
ing produced by replacing NaCl with 150 mM urea, neither in
the absence nor in the presence of 32 M nystatin (data not
shown). 2) Extracellular nucleotides can only act in an auto-
crine or paracrine fashion, because their mobility is restricted
by nucleotidases present in the plasma, on cellular elements of
the blood, and at the vascular wall. In contrast, RBCs aremobile
and therefore encounter quite different environments across
the circulatory system, not only in normal resting, but also in
stimulated and pathological conditions. For example, transient
high levels of ATP, ADP, and adenosine are involved in the
regulation of platelet aggregation (46), and RBCs may them-
FIGURE 7. Volumetric response of erythrocytes exposed to hypotonicmedium in the presence of forskolin. A, Vr versus time of cells exposed to isotonic
medium (C) and hypotonicmedium (HYPO) at 37 °C in the absence (closed circles) and presence (open circles) of 100M forskolin. Results aremeans S.E., n
19–22, n 1. B, values of RVD at 120 min estimated from experiments shown in A. *, p 0.05 versus HYPO.
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selves release adenylates in response to, e.g. mechanical stress
(47) or reduced oxygen tensions (48). 3) Finally, the nucleotide
metabolismmay depend on the RBC-specific location, the action
of ectonucleotidases from different cell types, and exonucleoti-
dases of the blood plasma (49). For example, leukocytes and endo-
thelial cells exhibit various degrees of ectoATPase and ectoAD-
Pase activities (50, 51), whereas AMP is mainly dephosphorylated
by a plasma 5-nucleotidase. The adenosine formed can interact
with specific P1 receptors, be deaminated extracellularly, or taken
up by erythrocytes through nucleoside transporters (52).
It is worth noting that the results obtained by fluorophore
quenching, where cells are attached to a coverslip, could be
reproduced by the use of a microhematocrit method using
cells in suspension. This and the finding that RVD can also be
observed at physiological temperature indicate that the RVD
machinery can be activated in vivo during a hypotonic
challenge.
For more than 50 years RBCs have been used as a simple cell
model to characterize metabolic pathways as well as transport
and signaling systems common to most animal cells. However,
investigations were in part limited by the idea that, duringmat-
uration and aging, erythrocytes lose the machinery for many
signaling systems, rendering many receptors obsolete (53–55).
This is why most biophysical and physicochemistry textbooks
used the anucleated erythrocyte as a model example to test the
validity of the van’t Hoff-Mariotte law, and, in general, volume
regulation of erythrocytes focused on all but normal mature
erythrocytes, i.e. on either nucleated non-mammalian cells,
mammalian reticulocytes, or sickle RBCs (7, 56–58). As a logi-
cal consequence, volume regulatory mechanisms in mature
RBCs remained largely unexplored.
The seminal work of Wang et al. (16) provided a crucial
advancement of our understanding of volume regulatorymech-
anisms, because it postulated a link between activation of a
surface “P” receptor and a mechanism to allow volume regula-
tion of swollen cells. Although the proposed model and subse-
quent reports mostly described an action of ATP on specific
P2Y receptors, the activities of ectonucleotidases made other
metabolites available as alternative agonists to modulate cell
volume. In linewith this,Wurm et al. (59) recently described an
activating effect of adenosine A1 receptors on RVD of retinal
glial cells using knockout mice. Results of our present study
now add to the number of possible scenarios showing that in
mature RBCs specific P1 receptors remain active, allowing
these cells to partially compensate the hypotonic swelling. The
complexity of volume regulatory signaling pathways apparently
increases as we look at it, and it remains to be seen which fur-
ther unexpected interactions between signaling pathways and
effectormechanisms of volume regulation are to be discovered.
In line, as this report was prepared, it was reported that in
human RBCs and in other human cells a KCl co-transport
involved in volume regulation and kept inactive by phosphory-
lation, KCC3, is dephosphorylated upon hypotonic exposure.
However, although this led to activation and enhanced ion
transport activity in other cells (60), this was apparently not the
case in RBCs, confirming the presence of an additional level of
control present in these cells.
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